Aviva’s Hamilton Lane HLNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Buy
5,460
+1,366
+33% +$121K ﹤0.01% 783
2026
Q1
$407K Buy
4,094
+246
+6% +$30.2K ﹤0.01% 789
2025
Q4
$517K Buy
3,848
+623
+19% +$78.3K ﹤0.01% 725
2025
Q3
$435K Buy
3,225
+116
+4% +$17.5K ﹤0.01% 838
2025
Q2
$442K Sell
3,109
-1,018
-25% -$153K ﹤0.01% 833
2025
Q1
$614K Buy
4,127
+793
+24% +$121K ﹤0.01% 683
2024
Q4
$494K Buy
3,334
+527
+19% +$93.9K ﹤0.01% 819
2024
Q3
$473K Buy
+2,807
New +$406K ﹤0.01% 812
2022
Q1
Sell
-23,897
Closed -$2.48M 1077
2021
Q4
$2.48M Buy
23,897
+4,430
+23% +$455K 0.01% 813
2021
Q3
$1.65M Buy
+19,467
New +$1.74M 0.01% 826

Other funds holding HLNE

Aviva's HLNE Position: Q2 2026 in Review

Aviva increased its Hamilton Lane (HLNE) stake by 33% in Q2 2026, buying an estimated $121K and bringing the position to 5,460 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Aviva first reported a position in HLNE in Q3 2021 and has held it in 10 quarters since. The position peaked at $2.48M in Q4 2021. 380 funds tracked by Wall St. Rank hold HLNE as of Q2 2026.

  • Aviva held 5,460 shares of Hamilton Lane worth $430K as of Q2 2026.
  • Aviva bought 1,366 Hamilton Lane shares in Q2 2026, an estimated $121K.
  • Hamilton Lane made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #783 holding.
  • Aviva first reported a position in Hamilton Lane in Q3 2021 and has held it in 10 quarters since.
  • Aviva's Hamilton Lane position peaked at $2.48M in Q4 2021.
  • 380 funds tracked by Wall St. Rank held Hamilton Lane as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.